Molecular methods for increasing the effectiveness of ovarian cancer treatment: a systematic review-Reference-Cited by-同舟云学术

Molecular methods for increasing the effectiveness of ovarian cancer treatment: a systematic review

Published:2022-04 Issue:13 Volume:18 Page:1627-1650
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Chilimoniuk Zuzanna¹^ORCID,Rocka Agata¹^ORCID,Stefaniak Martyna¹^ORCID,Tomczyk Żaklina¹^ORCID,Jasielska Faustyna¹^ORCID,Madras Dominika¹^ORCID,Filip Agata²^ORCID

Affiliation:

1. Students' Scientific Association at the Department of Cancer Genetics with Cytogenetics Laboratory, Medical University of Lublin, ul. Radziwiłłowska 11, Lublin, 20-080, Poland

2. Department of Cancer Genetics with Cytogenetics Laboratory, Medical University of Lublin, ul. Radziwiłłowska 11, Lublin, 20-080, Poland

Abstract

Background: The aim of the current study is to analyze and summarize the latest research on improving therapy in ovarian cancer. Materials & methods: Data analysis was based on a review of publications from 2011 to 2021 in the PubMed database with use of the search terms including ‘EGFR ovarian cancer’, ‘folate receptor inhibitors ovarian cancer’, ‘VEGF ovarian cancer’, ‘PDGF ovarian cancer’ and ‘CTLA-4 ovarian cancer’. Results: 6643 articles were found; 238 clinical trials and randomized control trials were analyzed; 122 studies were rejected due to inconsistency with the topic of the work. Conclusion: Extensive research on the treatment of ovarian cancer increases the chance of developing the most effective therapy suited to the individual needs of the patient.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2021-0565

Reference185 articles.

1. World Health Organization. ICBP SURVMARK-2 (2021). https://gco.iarc.fr/survival/survmark/visualizations/viz1/?groupby=%22country%22&period=%225%22&cancer_site=%22Ovary%22&country=%22Australia%22&year=%222014%22&gender=%22Females%22&sorting=%220%22

2. Survival Rates for Ovarian Cancer (2021). www.cancer.org/cancer/ovarian-cancer/detection-diagnosis-staging/survival-rates.html

3. World Health Organization. (2021). www.who.int/news-room/fact-sheets/detail/cancer

4. National Cancer Registration and Analysis Service. Short Term Ovarian Cancer Mortality (2021). www.ncin.org.uk/publications/data_briefings/short_term_ovarian_cancer_mortality

5. Cancer Facts & Figures (2020). www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/estimated-number-of-new-cancer-cases-and-deaths-by-sex-2020.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-04-18

2. A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents;Frontiers in Pharmacology;2022-08-24

3. Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway;Human & Experimental Toxicology;2022-01